Omental fat expression of adiponectin and adiponectin receptors in non-obese women with PCOS: A preliminary study

Reproductive BioMedicine Online

Volumn 19, Issue 4, 2009, Pages 577-582

  Seow, Kok Min ^a,b   Tsai, Yieh Loong ^a,b   Juan, Chi Chang ^c,d,e   Lin, Yu Hung ^a,b   Hwang, Jiann Loung ^a,g   Ho, Low Tone ^c,d,e,f  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c TAIPEI CITY HOSPITAL   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e Department of Medical Research and Education ^*  (Taiwan)

^f TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^g TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Adiponectin; Adiponectin receptor 1 and 2; Polycystic ovary syndrome

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; CYTOKINE; INSULIN; MESSENGER RNA;

ADIPOSE TISSUE; ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GLUCOSE HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERINSULINEMIA; INSULIN RESISTANCE; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 70449089022     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rbmo.2009.05.003     Document Type: Article

References (30)

1. Ardawi MS, Rouzi AA 2005 Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome. Fertility and Sterility 83, 1708-1716. (Pubitemid 40824803)
2. Aroda V, Ciaraldi TP, Chang SA et al. 2008 Circulating and cellular adiponectin in polycystic ovary syndrome: relationship to glucose tolerance and insulin action. Fertility and Sterility 89, 1200-1208. (Pubitemid 351671715)
3. Balen AH, Laven JS, Tan SL et al. 2003 Ultrasound assessment of the polycystic ovary: international consensus definitions. Human Reproduction Update 9, 505-514.
4. Burghen GA, Givens JR, Kitabchi AE 1980 Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. Journal of Clinical Endocrinology and Metabolism 50, 113-116. (Pubitemid 10203585)
5. Carmina E, Chu MC, Moran C et al. 2008 Subcutaneous and omental fat expression of adiponectin and leptin in women with polycystic ovary syndrome. Fertility and Sterility 89, 642-648. (Pubitemid 351337665)
6. Ciaraldi TP, Morales AJ, Hickman MG et al. 1997 Cellular insulin resistance in adipocytes from obese polycystic ovary syndrome subjects involves adenosine modulation of insulin sensitivity. Journal of Clinical Endocrinology and Metabolism 82, 1421-1425.
7. Corton M, Botella-Carretero JI, Benguria A et al. 2007 Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 92, 328-337. (Pubitemid 46075011)
8. Dunaif A 1992 Polycystic ovary syndrome and obesity. In: Bjorntorp P, Brodoff BN, editors Obesity. Philadelphia: Lippincott; 1992. p. 594.
9. Dunaif A 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Reviews 18, 774-800. (Pubitemid 28009567)
10. Kadowaki T, Yamauchi T 2005 Adiponectin and adiponectin receptors. Endocrine Reviews 26, 439-451.
11. Kadowaki T, Yamauchi T, Kubota N et al. 2006 Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. Journal of Clinical Investigation 116, 1784-1792. (Pubitemid 44033298)
12. Kauffman RP, Baker VM, Dimarino P et al. 2002 Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations. American Journal of Obstetrics and Gynecology 187, 1362-1369.
13. Legro RS, Finegood D, Dunaif A 1998 A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 83, 2694-2698. (Pubitemid 28493762)
14. Legro RS, Kunselman AR, Dodson WC et al. 1999 Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. Journal of Clinical Endocrinology and Metabolism 84, 165-169. (Pubitemid 29036695)
15. Matsuda M, DeFronzo R 1999 Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22, 1462-1470. (Pubitemid 29418240)
16. Matthews DR, Hosker JP, Rudenski AS et al. 1985 Homeostasis model assessment: insulin resistance and [beta]-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419.
17. Nishizawa H, Shimomura I, Kishida K et al. 2002 Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 51, 2734-2741. (Pubitemid 34970926)
18. Orio Jr F, Palomba S, Cascella T et al. 2003 Adiponectin levels in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 88, 2619-2623. (Pubitemid 36724434)
19. Panidis D, Korutis A, Farmakiotis D et al. 2003 Serum adiponectin levels in women with polycystic ovary syndrome. Human Reproduction 18, 2619-2623. (Pubitemid 37107549)
20. Rodbell M 1964 Metabolism of isolated fat cell. I. Effects of hormone on glucose metabolism and lipolysis. Journal of Biological Chemistry 239, 375-380.
21. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Human Reproduction 19, 41-47. (Pubitemid 38072004)
22. Scherer PE, Williams S, Fogliano M et al. 1995 A novel serum protein similar to C1q, produced exclusively in adipocytes. Journal of Biological Chemistry 270, 26746-26749.
23. Seow KM, Juan CC, Wu YL et al. 2004 Serum and adipocyte resistin in polycystic ovarian syndrome with insulin resistance. Human Reproduction 19, 48-53. (Pubitemid 38072005)
24. Shapiro L, Scheree PE 1998 The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Current Biology 8, 335-338. (Pubitemid 28159119)
25. Sieminska L, Marek B, Kos-Kudla B et al. 2004 Serum adiponectin in women with polycystic ovary syndrome and its relation to clinical, metabolic and endocrine parameters. Journal of Endocrinology Investigation 27, 528-534. (Pubitemid 39255502)
26. Spranger J, Mohlig M, Wegewitz U et al. 2004 Adiponectin is independently associated with insulin sensitivity in women wit hpolycystic ovary syndrome. Clinical Endocrinology (Oxford) 61, 738-746. (Pubitemid 40006795)
27. Tan BK, Chen J, Digby JE et al. 2006 Upregulation of adiponectin receptor 1 and 2 mRNA and protein in adipose tissue and adipocytes in insulin-resistant women with polycystic ovary syndrome. Diabetologia 49, 2723-2728.
28. Toprak S, Yonem A, Cakir B et al. 2001 Insulin resistance in non-obese patients with polycystic ovary syndrome. Hormone Research 55, 65-70. (Pubitemid 32757360)
29. Tsao TS, Lodish HF, Fruebis J 2002 ACR30, a new hormone controlling fat and glucose metabolism. European Journal of Pharmacology 440, 213-221. (Pubitemid 34458025)
30. Tsuchida A, Yamauchi T, Ito Y et al. 2004 Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. Journal of Biological Chemistry 279, 30817-30822. (Pubitemid 38938015)